Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 11:13 PM
NCT ID:
NCT03569293
Pre Assignment Details:
Participants were randomized equally into 1 of 3 treatment groups, stratified by disease severity (validated Investigator Global Assessment Scale for Atopic Dermatitis \[vIGA-AD\] moderate \[3\] vs severe \[4\]), geographic region (US/Puerto Rico/Canada, Japan, China, and Other), and age (adolescent \[ages 12 to 17\] vs adult \[ages 18 to 75\]). Randomization for the adolescent substudy was stratified by disease severity (vIGA-AD 3 vs vIGA-AD 4) and geographic region (US/Puerto Rico/Canada vs Other).
Recruitment Details:
Participants were enrolled at 151 study sites in 24 countries across Europe, North and South America, Oceania, and the Asia-Pacific region.
The study included a 16-week double-blind treatment period followed by an ongoing blinded extension period.
The first 810 adults and adolescents enrolled constituted the Main Study; additional adolescents were enrolled in the Adolescent Substudy to ensure enrollment of a total of 180 adolescent participants overall.
Results are reported up to Week 16.
Study:
NCT03569293
Study Brief:
Results Section:
NCT03569293